Document is current
Any future updates will be listed below
-
Authors
Puspitasari, Agatha Mia
Sutanto, Edwin
Syauqi, Khilal
Amalia, Ristya
Nisa, Fahira Ainun
Trianty, Leily
Sidhartha, Elizabeth
Kenangalem, Enny
Poespoprodjo, Jeanne Rini
Ahmed, Rukhsana
Owusu, Ewurama
Carlier, Lise
Tetteh, Kevin K. A.
Cheng, Qin
Noviyanti, Rintis
-
Funding
Funding for this research was provided by:
Exeins Health Initiative
Gates Foundation through Foundation for Innovative Diagnostics
- License Information
-
More Information
Article History
Received: 16 December 2024
Accepted: 16 May 2025
First Online: 4 June 2025
Declarations
:
: The authors declare no competing interests.
: The study protocol was approved by the ethics committee of Eijkman Institute for Molecular Biology (EIMB) and Atma Jaya Catholic University of Indonesia (Ethical Clearance Numbers: 170/EIREC/2021 and 0008U/III/PPPE.PM.10.05/10/2022, respectively). The informed consent was written in English, then translated to the national language, Bahasa Indonesia, to ensure all information was correctly delivered to eligible participants. In addition, the informed consent was prepared in three age categories: child (5–12 y.o.), adolescent (13–17 y.o.), and adult (above 18 y.o.). For illiterate individuals, the informed consent process was conducted with an impartial witness where the participant thumb-printed and the witness signed the form. For children, assent was obtained from the child and the participant’s parents or guardians would either sign or thumb-print if consented to participate. All experiments were conducted following the relevant guidelines and regulations in accordance with the Declaration of Helsinki.
